Facing ‘last stand’ obstacles from whiny scientists at NIH who do not like their research directed by “we the people” to a threatened ‘hold’ by a lone Senator … U.S. Senator Sheldon Whitehouse (D-RI) maneuvered the Recalcitrant Cancer Research Act of 2012 which had passed the House of Representatives unanimously with bi-partisan support earlier this Fall from an at-risk stand-alone bill to an amendment to the National Defense Authorization Act.
Now the ‘amended’ National Defense Authorization Act goes back to the House of Representatives for approval of changes.
Why does it even matter? It redirects the previously funded federal research by the National Cancer Institute to target the "most deadly cancers" while adding zero cost to the budget. Priority status given to pancreatic cancer (5 yr survival rate = 4%) and lung cancer (5 yr survival rate = 15%). Plus it's personal ...
Why does it matter NOW? In parliamentary terms, it’s ‘old business’ of the 112th US Congress which ends on January 3, 2013. If not signed into law by the President before then the clock resets to scratch on legislation that has been years in the works.
As frustrated as I may get ‘watching’ this, I do want to give a Christmas shout out to Senators Sheldon Whitehouse (D-RI), Carl Levin (D-MI) and John McCain (R-AZ) for standing up and believing in survival.
Now like everything else, forget the Mayan calendar, the better question is what and who among us will survive the Obama/Boehner ‘Cliff’mas holidays?
Caregivingly Yours, MS Caregiver @ http://caregivinglyyours.blogspot.com/
My Lung Cancer Odyssey @ http://lung-cancer-survivor.blogspot.com/